Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

FORTRESS BIOTECH INC (FBIO)

50 + Investors. Track Smart Money conviction in FBIO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -6
Streak
1Q ▼
Buyers last Q
48%

Smart Money Signals — FBIO

Based on 52 hedge funds · latest filing: 2025 Q4 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their FBIO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 90% of 3.0Y peak

90% of all-time peak
52 funds currently hold this stock — 90% of the 3.0-year high of 58 funds (reached 2025 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding FBIO is almost the same as a year ago (-1 funds, -2% change). No significant rush to buy or sell — institutional backing is holding steady.
🟠

More sellers than buyers — 48% buying

30 buying33 selling
Last quarter: 33 funds reduced or exited vs 30 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-9 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 2 → 11 → 20 → 11. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 37% long-term, 35% new

■ 37% conviction (2yr+) ■ 29% medium ■ 35% new
Of the 52 current holders: 19 (37%) held >2 years, 15 held 1–2 years, and 18 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
📈

Growing discovery — still being found

11 → 2 → 11 → 20 → 11 new funds/Q
New funds entering each quarter: 2 → 11 → 20 → 11. A growing number of institutions are discovering FBIO each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
📊

Mixed cohorts — 5% veterans, 38% new entrants

■ 5% veterans ■ 57% 1-2yr ■ 38% new
Of 56 current holders: 3 (5%) held 2+ years, 32 held 1–2 years, 21 (38%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 39% AUM from major funds

39% from top-100 AUM funds
15 of 52 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.7
out of 10
Low Exit Risk
Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — FBIO

In 2025 Q4, 30 hedge funds were net buyers of FBIO (11 opened a new position, 19 added to an existing one), while 33 reduced or exited (16 trimmed, 17 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. 39% of total institutional value in FBIO is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -6 funds (more exits than new entries). Total institutional holders: 52.

Hedge Fund Ownership: FBIO

How many hedge funds hold FBIO — quarterly history vs. share price
Quarterly hedge fund ownership of FBIO vs. share price

Market Analysis: FBIO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: FBIO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy FORTRESS BIOTECH INC (FBIO) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much FBIO has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 51d ago
FBIO
+7.1%
XLV
+352.2%

FBIO outperformed XLV by -345.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 6d ago
FBIO
+10.0%
XLV
+386.1%

Since the filing became public, FBIO outperformed XLV by -376.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

3 top-rated funds 0 high-conviction
Consensus
2.6
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: FBIO
50 + Investors

Track Smart Money conviction in FBIO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 50 52 -3.85%
13F Shares 6M 6M -11.28%
Total Value $14M $24M -40.63%
New Positions 11 11 -
Increased Positions 13 18 -5
Closed Positions 13 17 -4
Reduced Positions 15 15 -
Total Calls 2 2 -
Total Puts 2 4 -50.0%
PUT/CALL Ratio 1.0 2.0 Neutral

Statistics: FBIO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

50 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in FBIO. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of FBIO — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Opaleye Management Inc. 0.38% 1,042,000 $2.9M
2 SHIKIAR ASSET MANAGEMENT INC 0.25% 305,469 —
3 GSA CAPITAL PARTNERS LLP 0.04% 254,134 —
4 180 WEALTH ADVISORS, LLC 0.02% 63,800 $178K
5 BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% 182,368 $509K
6 TWO SIGMA SECURITIES, LLC 0.01% 24,744 $69K
7 Weaver Consulting Group 0.01% 11,367 $32K
8 Abacus Planning Group, Inc. 0.01% 14,534 $41K
9 PFG Investments, LLC 0.00% 36,501 $102K
10 MTM Investment Management, LLC 0.00% 4,249 $12K
11 XTX Topco Ltd 0.00% 76,068 $212K
12 HB Wealth Management, LLC 0.00% 120,175 $335K
13 Kestra Advisory Services, LLC 0.00% 129,801 $362K
14 CHOREO, LLC 0.00% 36,250 $101K
15 Integrated Wealth Concepts LLC 0.00% 45,200 $126K
16 Tower Research Capital LLC (TRC) 0.00% 10,495 $29K
17 Summit Financial, LLC 0.00% 20,659 $58K
18 NewEdge Advisors, LLC 0.00% 12,927 $13K
19 PANAGORA ASSET MANAGEMENT INC 0.00% 56,668 $158K
20 TWO SIGMA INVESTMENTS, LP 0.00% 196,825 $549K
21 RENAISSANCE TECHNOLOGIES LLC 0.00% 99,590 $278K
22 Forum Financial Management, LP 0.00% 10,000 $28K
23 TWO SIGMA ADVISERS, LP 0.00% 25,250 $92K
24 ACADIAN ASSET MANAGEMENT LLC 0.00% 40,450 —
25 Caitong International Asset Management Co., Ltd 0.00% 213 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — FORTRESS BIOTECH INC (FBIO)

What does the Smart Money Trend signal show for FBIO?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their FBIO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for FBIO?

More sellers than buyers — 48% buying: Last quarter: 33 funds reduced or exited vs 30 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for FBIO holders?

Strong quality — 39% AUM from major funds: 15 of 52 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held FBIO?

Mixed — 37% long-term, 35% new: Of the 52 current holders: 19 (37%) held >2 years, 15 held 1–2 years, and 18 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy FORTRESS BIOTECH INC (FBIO) following the 2026 Q1 hedge fund 13F filings?

As of today, FBIO has moved +10.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +386.1% for the XLV sector ETF — an outperformance of -376.1%. Since the quarter end (March 31, 2026), FBIO has gained +7.1% vs +352.2% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →